North Ridgeville City Schools 34600 Bainbridge Road North Ridgeville, Ohio 44039
Thomas Szendrey - Principal Petie Bianca - Asst. Principal Joy Morgan – Asst. Principal
Parents of 12th Graders in Fall 2017
To:
Date: March 23, 2017 Meningococcal Vaccination Requirement for 12th Grade Entry
Re:
Per the Ohio Revised Code 3701.13, all students entering 12th grade are required to have a written record on file at school of having received a 2nd dose of Meningococcal vaccine on or after their 16th birthday. Your child may or may not have already had this vaccine. The school does not have proof on file at this time. Please contact your health care provider for your child’s immunization record showing this vaccine date. If your child has not had a Meningococcal vaccine, you may obtain it from your health care provider or other community providers such as the Lorain County General Health District. You can schedule an appointment by calling 440-284-3206. Note: Ask your provider about additional vaccines that are recommended for children ages 11-19 such as 2nd dose of varicella (chicken pox), hepatitis A and human papillomavirus (HPV) vaccines. Proof must be provided to the school for the Meningococcal vaccine. Have your physician/provider complete the bottom of this letter or you may submit a current copy of your child’s immunization record. Rose Hess RN. BSN. LSN. North Ridgeville City Schools 34600 Bainbridge North Ridgeville, Oh. 44039 Student’s Name: _____________________________ Date of birth: ______________________ Vaccine(s) received:
Meningococcal date of vaccination: _______________
Other vaccine - date: ______________
Other vaccine - date: ______________
Provider’s Stamp/Name, Address, Phone
Signature____________________________
*PROOF OF VACCINATION MUST BE RETURNED TO SCHOOL BY September 6, 2017 Or schedules will not be released through the parent portal.
Sep 28, 2017 - injection Haemophilus type b and Meningococcal group C conjugate vaccine. UK/H/0954/001. PA1077/116/001. GLAXOSMITHKLINE. (IRELAND) LIMITED. IE. Menitorix, proszek i rozpuszczalnik do sporzÄ dzania roztworu do wstrzykiwaÅ. Szczepionka
Jan 30, 2017 - Lucas State Office Building, 321 E. 12th Street, Des Moines, IA 50319-0075 ... requirement will help Iowa achieve and maintain high adolescent.
European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. 28 September 2017. EMA/631269/2017. Human Medicines Evaluation Division. List of nationally authorised medicinal products. Active substance: haemophilus
Loading⦠Whoops! There was a problem loading more pages. Retrying... Whoops! There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. Meningococcal letter 2017.pdf
Page 1 of 1. TITLE 77: PUBLIC HEALTH. CHAPTER I: DEPARTMENT OF PUBLIC HEALTH. SUBCHAPTER i: MATERNAL AND CHILD HEALTH. PART 665 CHILD HEALTH EXAMINATION CODE. SECTION 665.240 BASIC IMMUNIZATION. Section 665.240 Basic Immunization. j) Meningococcal Di
There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. Influenza Vaccine Information.pdf. Influenza Vaccine Information.pdf. Open. Extract. Open with. Sign In. Mai
Meningococcal Disease Snapshot. ⢠Meningococcal disease is a rare, but potentially deadly, bacterial infection that can take the form of meningitis (an inflammation of the membranes surrounding the brain and spinal cord) or meningococcemia (a blood
National Foundation for Infectious Diseases, www.nfid.org. ⢠National Meningitis Association, www.nmaus.org. Source: NASN Get the Facts! 2006, CDC 2006, WI.gov.communicable disease Fact Sheets/Meningococcal 2006. For additional information about me
Feb 15, 2011 - Applications are invited for the VRI Awards from young scientists to work at the Vaccine and Infectious Disease. Research Centre (VIDRC), a ...
Apr 14, 2016 - 30 Churchill Place â Canary Wharf â London E14 5EU â United Kingdom. An agency of ... Procedure Management and Committees Support.
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för
Feb 15, 2011 - scientists to work at the Vaccine and Infectious Disease. Research Centre ... shall not be entitled to draw any other fellowship or salary.